Cargando…

Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy

Patient-specific assessment, disease monitoring, and the development of an accurate early surrogate of the therapeutic efficacy of locally advanced prostate cancer still remain a clinical challenge. Contrary to prostate biopsies, circulating tumor cell (CTC) collection from blood is a less-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wark, Landon, Quon, Harvey, Ong, Aldrich, Drachenberg, Darrel, Rangel-Pozzo, Aline, Mai, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721586/ https://www.ncbi.nlm.nih.gov/pubmed/31416141 http://dx.doi.org/10.3390/cancers11081165

Ejemplares similares

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
por: Drachenberg, Darrel, et al.
Publicado: (2019)

Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level
por: Rangel-Pozzo, Aline, et al.
Publicado: (2020)

Three-dimensional telomere profiles in papillary thyroid cancer variants: A pilot study
por: Rangel-Pozzo, Aline, et al.
Publicado: (2022)

Three-dimensional nuclear telomere architecture and differential expression of aurora kinase genes in chronic myeloid leukemia to measure cell transformation
por: de Oliveira, Fábio Morato, et al.
Publicado: (2022)

Genomic Instability in Circulating Tumor Cells
por: Freitas, Monique Oliveira, et al.
Publicado: (2020)

Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients
por: Rangel-Pozzo, Aline, et al.
Publicado: (2022)

The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysis
por: Nayak, Jasmir G, et al.
Publicado: (2014)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Yu, Pak Lok Ivan, et al.
Publicado: (2019)

3D Telomere Structure Analysis to Detect Genomic Instability and Cytogenetic Evolution in Myelodysplastic Syndromes
por: Rangel-Pozzo, Aline, et al.
Publicado: (2019)

Telomere Architecture Correlates with Aggressiveness in Multiple Myeloma
por: Rangel-Pozzo, Aline, et al.
Publicado: (2021)

Identification of Neuroblastoma Subgroups Based on Three-Dimensional Telomere Organization()()
por: Kuzyk, Alexandra, et al.
Publicado: (2016)

The impact of androgen deprivation on artificial urinary sphincter outcomes
por: Bailey, George C., et al.
Publicado: (2016)

Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis
por: Sheng, Mingxiong, et al.
Publicado: (2021)

Distinct 3D Structural Patterns of Lamin A/C Expression in Hodgkin and Reed-Sternberg Cells
por: Contu, Fabio, et al.
Publicado: (2018)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy
por: Kojima, Ippei, et al.
Publicado: (2019)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Analysis of the circulating myeloid‐derived suppressor cells during androgen deprivation therapy for prostate cancer
por: Kohada, Yuki, et al.
Publicado: (2021)

Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
por: Memon, Maaz A., et al.
Publicado: (2022)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
por: Lim, Jasmine, et al.
Publicado: (2020)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

High Mobility Group A2 protects cancer cells against telomere dysfunction
por: Natarajan, Suchitra, et al.
Publicado: (2016)

Thoracoabdominal Approach for Large Retroperitoneal Masses: Case Series and Review
por: Venkat, Siv, et al.
Publicado: (2019)

Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?
por: Cabarkapa, Sonja, et al.
Publicado: (2018)

Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
por: Cherrier, M. M., et al.
Publicado: (2018)

Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy
por: Shin, Dongseong, et al.
Publicado: (2020)

The three-dimensional organization of telomeres in the nucleus of mammalian cells
por: Chuang, Tony Chih Yuan, et al.
Publicado: (2004)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Androgen deprivation therapy increases brain ageing
por: Plata-Bello, Julio, et al.
Publicado: (2019)

Androgen Deprivation Therapy–Induced Cardiovascular Disease
por: Dhanushkodi, Manikandan
Publicado: (2016)

Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020)

Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3c6vepjqhr6d6bkqq80p76fdmi